Abbott
Daniel Salvadori is Abbott's Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products. He was appointed to this role in December 2021.
Previously, Daniel served as Abbott's Executive Vice President, Nutritional Products, and as Senior Vice President, Established Pharmaceuticals, Latin America.
Prior to joining Abbott, Daniel was Chief Executive Officer, LATAM for CFR Pharmaceuticals.
Daniel earned his master's degree in business administration from the Harvard Business School, Boston, Massachusetts. He is fluent in English, Spanish, French and Italian.
This person is not in any offices
Abbott
374 followers
Abbott is a healthcare company that develops products to improve quality of life at all stages. Abbott’s portfolio includes diagnostics, medical devices, nutritionals and branded generic medicines. They have over 110,000 employees globally with customers in over 160 countries worldwide. With 130 years of history, Abbott is an established presence in the healthcare industry. Abbott’s portfolio has products targeted towards several categories, including cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines. Some of Abbott’s best known brands include: Similac, a line of infant formulas; EleCare, a nutritionally complete, amino acid-based medical good and infant formula with iron; PediaSure, balanced nutrition for kids on the go; Pedialyte, a formulation to prevent dehydration by restoring lost minerals and nutrients; Ensure, a line of nutrition products supporting active lifestyles; FreeStyle, a glucose monitor to make managing diabetes easier and more convenient; FreeStyle Libre, a handheld reader with a small sensor that continuously monitors glucose levels, eliminating routine finger sticks; and Glucerna, specialized nutrition to help maintain health blood glucose levels and manage diabetes.